HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E H Ohlstein Selected Research

idoxifene

2/2001Endothelial protective and antishock effects of a selective estrogen receptor modulator in rats.
11/2000Selective estrogen receptor modulator idoxifene inhibits smooth muscle cell proliferation, enhances reendothelialization, and inhibits neointimal formation in vivo after vascular injury.
11/2000Nitric oxide stimulatory and endothelial protective effects of idoxifene, a selective estrogen receptor modulator, in the splanchnic artery of the ovariectomized rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


E H Ohlstein Research Topics

Disease

9Ischemia
11/2001 - 03/2000
6Stroke (Strokes)
10/2001 - 11/2000
4Infarction (Infarctions)
03/2001 - 10/2000
3Reperfusion Injury
11/2001 - 03/2000
3Myocardial Infarction
11/2001 - 10/2000
3Cardiomegaly (Heart Hypertrophy)
10/2001 - 06/2001
3Vascular System Injuries
11/2000 - 01/2000
3Neointima
11/2000 - 04/2000
2Diabetic Nephropathies (Diabetic Nephropathy)
10/2008 - 08/2001
2Heart Failure
10/2001 - 08/2000
2Renal Insufficiency (Renal Failure)
08/2001 - 06/2001
2Hypertension (High Blood Pressure)
06/2001 - 08/2000
2Brain Injuries (Brain Injury)
03/2001 - 02/2001
2Shock
02/2001 - 11/2000
2Atherosclerosis
04/2000 - 01/2000
1Body Weight (Weight, Body)
10/2001
1Ventricular Remodeling
10/2001
1Clinical Deterioration
09/2001
1Chronic Kidney Failure (Chronic Renal Failure)
08/2001
1Atrophy
08/2001
1Cardiomyopathies (Cardiomyopathy)
06/2001
1Ischemic Stroke
03/2001
1Hypotension (Low Blood Pressure)
02/2001
1Arthritis (Polyarthritis)
02/2001
1Hypertrophy
12/2000
1Brain Edema (Cerebral Edema)
11/2000
1Brain Ischemia (Cerebral Ischemia)
11/2000
1Edema (Dropsy)
11/2000
1Craniocerebral Trauma (Head Injury)
11/2000
1Inflammation (Inflammations)
11/2000
1Closed Head Injuries
11/2000
1Endometrial Neoplasms (Endometrial Cancer)
11/2000
1Myocardial Ischemia (Ischemic Heart Diseases)
10/2000
1Cardiovascular Diseases (Cardiovascular Disease)
08/2000
1Atherosclerotic Plaque (Atheroma)
08/2000
1Hypoxia (Hypoxemia)
05/2000
1Pulmonary Hypertension
05/2000

Drug/Important Bio-Agent (IBA)

5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2001 - 01/2000
4CytokinesIBA
09/2001 - 01/2000
3p38 Mitogen-Activated Protein KinasesIBA
09/2001 - 02/2001
3idoxifeneIBA
02/2001 - 11/2000
2SaltsIBA
10/2001 - 09/2001
2Endothelins (Endothelin)IBA
10/2001 - 11/2000
2Matrix Metalloproteinases (MMPs)IBA
08/2001 - 01/2001
2Endothelin-1 (Endothelin 1)IBA
08/2001 - 12/2000
2SB 239063IBA
03/2001 - 02/2001
2Selective Estrogen Receptor Modulators (SERM)IBA
02/2001 - 11/2000
2Estrogens (Estrogen)FDA Link
02/2001 - 11/2000
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
12/2000 - 03/2000
2AntioxidantsIBA
10/2000 - 08/2000
2Carvedilol (Coreg)FDA LinkGeneric
10/2000 - 08/2000
2Vasoconstrictor AgentsIBA
08/2000 - 05/2000
2urotensin IIIBA
08/2000 - 05/2000
11- (2- (4- benzyl- 4- hydroxypiperidin- 1- yl)ethyl)- 3- (2- methylquinolin- 4- yl)ureaIBA
10/2008
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
11/2001
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
11/2001
1L-SelectinIBA
11/2001
1PPAR-gamma AgonistsIBA
11/2001
1Rosiglitazone (Avandia)FDA Link
11/2001
1Endothelin Receptor AntagonistsIBA
10/2001
1enrasentanIBA
10/2001
1Neurotransmitter Agents (Neurotransmitter)IBA
09/2001
1progelatinaseIBA
08/2001
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
08/2001
1eprosartan (Teveten)FDA Link
06/2001
1Angiotensin IIIBA
06/2001
1Phosphotransferases (Kinase)IBA
03/2001
1Dihydrotachysterol (AT 10)IBA
02/2001
1LipopolysaccharidesIBA
02/2001
1Phenylephrine (Neo-Synephrine)FDA LinkGeneric
12/2000
1Proliferating Cell Nuclear Antigen (PCNA)IBA
11/2000
1Vasodilator Agents (Vasodilators)IBA
11/2000
1(1S,2R,3S)- 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)- 4- methoxyphenyl)- 2,3- dihydro- 5- propoxy- 1H-Indene-2-carboxylic acidIBA
11/2000
1SB 234551IBA
11/2000
1Acetylcholine (Acetylcholine Chloride)FDA Link
11/2000
1Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2000
1Peptides (Polypeptides)IBA
11/2000
1Arachidonic Acid (Vitamin F)IBA
11/2000
1Endothelin A ReceptorIBA
11/2000
1Endothelin B ReceptorIBA
11/2000
1GTP-Binding Proteins (G-Protein)IBA
10/2000
1Adrenergic Receptors (Adrenergic Receptor)IBA
10/2000
1Peroxidase (Myeloperoxidase)IBA
10/2000
1Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA
10/2000
1Bisoprolol (Concor)FDA LinkGeneric
10/2000
1tranilastIBA
09/2000
1CollagenIBA
09/2000
1Metoprolol (Toprol-XL)FDA LinkGeneric
08/2000
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
08/2000
1Nitroarginine (NG Nitro L Arginine)IBA
05/2000
1NG-Nitroarginine Methyl Ester (L-NAME)IBA
05/2000
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
04/2000
1Interleukin-1 (Interleukin 1)IBA
04/2000
1Interleukin-1beta (Interleukin 1 beta)IBA
04/2000
12- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA
03/2000
1Transforming Growth Factor beta (TGF-beta)IBA
01/2000
1Messenger RNA (mRNA)IBA
01/2000

Therapy/Procedure

1Lung Transplantation
08/2001
1Sutures (Suture)
11/2000
1Therapeutics
11/2000